JP2017524348A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017524348A5 JP2017524348A5 JP2016572566A JP2016572566A JP2017524348A5 JP 2017524348 A5 JP2017524348 A5 JP 2017524348A5 JP 2016572566 A JP2016572566 A JP 2016572566A JP 2016572566 A JP2016572566 A JP 2016572566A JP 2017524348 A5 JP2017524348 A5 JP 2017524348A5
- Authority
- JP
- Japan
- Prior art keywords
- ptpn2
- leukocytes
- cell
- inhibitor
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014902203A AU2014902203A0 (en) | 2014-06-10 | Method of producing cells for adoptive cell transfer | |
| AU2014902203 | 2014-06-10 | ||
| AU2015901171A AU2015901171A0 (en) | 2015-03-31 | Method of producing cells for adoptive cell transfer (2) | |
| AU2015901171 | 2015-03-31 | ||
| PCT/AU2015/050318 WO2015188228A1 (en) | 2014-06-10 | 2015-06-10 | Method of producing leukocytes using ptpn2 inhibition for adoptive cell transfer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017524348A JP2017524348A (ja) | 2017-08-31 |
| JP2017524348A5 true JP2017524348A5 (enExample) | 2018-06-07 |
Family
ID=54832624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016572566A Pending JP2017524348A (ja) | 2014-06-10 | 2015-06-10 | 養子細胞移入のためのｐｔｐｎ２阻害を用いた白血球の産生方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20170224731A1 (enExample) |
| EP (1) | EP3154555A4 (enExample) |
| JP (1) | JP2017524348A (enExample) |
| AU (1) | AU2015274242A1 (enExample) |
| WO (1) | WO2015188228A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2557123B (en) | 2015-07-31 | 2021-11-03 | Univ Minnesota | Modified cells and methods of therapy |
| GB2573406B (en) | 2016-10-18 | 2021-11-10 | Univ Minnesota | Tumor infiltrating lymphocytes and methods of therapy |
| WO2018148378A1 (en) * | 2017-02-08 | 2018-08-16 | Dana-Farber Cancer Institute, Inc. | Modulating biomarkers to increase tumor immunity and improve the efficiacy of cancer immunotherapy |
| JP2020530307A (ja) | 2017-06-30 | 2020-10-22 | インティマ・バイオサイエンス，インコーポレーテッド | 遺伝子治療のためのアデノ随伴ウイルスベクター |
| CA3073755A1 (en) | 2017-08-24 | 2019-02-28 | The Royal Institution For The Advancement Of Learning/Mcgill Universit | Enhancing cd8+ t cells for adoptive cell therapy by inhibiting ptpn1 (ptp1b) and ptpn2 (tc-ptp) |
| US20190284553A1 (en) | 2018-03-15 | 2019-09-19 | KSQ Therapeutics, Inc. | Gene-regulating compositions and methods for improved immunotherapy |
| WO2019178420A1 (en) | 2018-03-15 | 2019-09-19 | KSQ Therapeutics, Inc. | Gene-regulating compositions and methods for improved immunotherapy |
| CA3093968A1 (en) * | 2018-03-15 | 2019-09-19 | KSQ Therapeutics, Inc. | Gene-regulating compositions and methods for improved immunotherapy |
| WO2019227176A1 (en) * | 2018-06-01 | 2019-12-05 | Monash University | Methods of activating cells via ptp 1b inhibition |
| KR102533477B1 (ko) | 2018-06-21 | 2023-05-18 | 칼리코 라이프 사이언시스 엘엘씨 | 단백질 타이로신 포스파타아제 억제제 및 그의 사용 방법 |
| US20220081691A1 (en) * | 2018-08-07 | 2022-03-17 | Dana-Farber Cancer Institute, Inc | Modulating ptpn2 to increase immune responses and perturbing gene expression in hematopoietic stem cell lineages |
| CA3128823A1 (en) * | 2019-02-04 | 2020-08-13 | KSQ Therapeutics, Inc. | Combination gene targets for improved immunotherapy |
| AU2020234712B2 (en) | 2019-03-14 | 2025-12-04 | Abbvie Inc. | Protein tyrosine phosphatase inhibitors and methods of use thereof |
| US12188045B2 (en) | 2019-06-07 | 2025-01-07 | KSQ Therapeutics, Inc. | Guide RNA combinations and methods of use |
| KR20220119038A (ko) * | 2019-11-25 | 2022-08-26 | 케이에스큐 세러퓨틱스 인코포레이티드 | 종양 침윤 림프구의 활성화 및 확장을 위한 방법 |
| AU2020395612A1 (en) * | 2019-12-04 | 2022-06-09 | Monash University | Methods of activating cytotoxic leukocytes using PTP1B and PTPN2 inhibitors |
| EP4073242A4 (en) * | 2019-12-12 | 2024-01-03 | Kumquat Biosciences Inc. | Compositions and methods for potentiating immune activity |
| CN113827727B (zh) * | 2020-06-24 | 2025-04-29 | 上海交通大学医学院附属瑞金医院 | Ptpn2抑制剂在kras突变肿瘤中的应用 |
| IL311570A (en) | 2021-10-14 | 2024-05-01 | Arsenal Biosciences Inc | Immune cells with common expression chain and logic gate systems |
| JP2026507228A (ja) | 2023-03-03 | 2026-02-27 | アーセナル バイオサイエンシズ インコーポレイテッド | Ｐｓｍａ及びｃａ９を標的とするシステム |
| EP4720059A1 (en) | 2023-05-24 | 2026-04-08 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| WO2025075947A1 (en) * | 2023-10-06 | 2025-04-10 | Purdue Research Foundation | Selective tc-ptp degraders for cancer immunotherapy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008043181A1 (en) * | 2006-10-12 | 2008-04-17 | Mcgill University | Augmenting stem cell populations by modulating t-cell protein tyrosine phosphatase (tc-ptp) |
| US9217012B2 (en) * | 2009-04-08 | 2015-12-22 | Indiana University Research And Technology Corporation | Inhibitors of protein tyrosine phosphatases |
| US9937205B2 (en) * | 2012-09-04 | 2018-04-10 | The Trustees Of The University Of Pennsylvania | Inhibition of diacylglycerol kinase to augment adoptive T cell transfer |
| AR092745A1 (es) * | 2012-10-01 | 2015-04-29 | Univ Pennsylvania | Composiciones que comprenden un dominio de union anti-fap y metodos para hacer blanco en celulas estromales para el tratamiento del cancer |
| WO2014066137A1 (en) * | 2012-10-22 | 2014-05-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Compositions and methods for enhancing cancer immunotherapy |
| RU2725542C2 (ru) * | 2013-05-13 | 2020-07-02 | Селлектис | Способы конструирования высокоактивных т-клеток для иммунотерапии |
| ES2897579T3 (es) * | 2013-06-10 | 2022-03-01 | Dana Farber Cancer Inst Inc | Métodos y composiciones para reducir la inmunosupresión por células tumorales |
| CN106471004A (zh) * | 2014-02-28 | 2017-03-01 | 麦吉尔大学学术发展皇家学院 | 作为用于免疫疗法的apc活化剂的tc‑ptp抑制剂 |
| MX373460B (es) * | 2014-03-11 | 2020-04-07 | Cellectis | Metodo para generar celulas t compatibles para el trasplante alogenico. |
-
2015
- 2015-06-10 US US15/317,197 patent/US20170224731A1/en not_active Abandoned
- 2015-06-10 EP EP15807341.1A patent/EP3154555A4/en not_active Withdrawn
- 2015-06-10 AU AU2015274242A patent/AU2015274242A1/en not_active Abandoned
- 2015-06-10 JP JP2016572566A patent/JP2017524348A/ja active Pending
- 2015-06-10 WO PCT/AU2015/050318 patent/WO2015188228A1/en not_active Ceased
-
2020
- 2020-09-08 US US17/014,737 patent/US20210052648A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11180730B2 (en) | Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3 | |
| JP2023055884A5 (enExample) | ||
| JP2018523668A5 (enExample) | ||
| US20190106678A1 (en) | Compositions and methods for evaluating and modulating immune responses by detecting and targeting pou2af1 | |
| MX2022006854A (es) | Composiciones y metodos de arn circular. | |
| JP2019509029A5 (enExample) | ||
| IL300282A (en) | Preparations and methods for cell programming using targeted nucleic acid nanocarriers | |
| US20260078383A1 (en) | Rna nanostructures and methods of making and using rna nanostructures | |
| US20170020922A1 (en) | Gene editing for immunological destruction of neoplasia | |
| JP2019527055A5 (enExample) | ||
| JP2017508744A5 (enExample) | ||
| JP2013530689A5 (enExample) | ||
| RU2017139121A (ru) | Композиции для модулирования экспрессии c9orf72 | |
| JP2020528744A5 (enExample) | ||
| JP2013521789A5 (enExample) | ||
| US20170304418A1 (en) | Universal donor checkpoint inhibitor silenced/gene edited cord blood killer cells | |
| JP2019512020A5 (enExample) | ||
| JP2018530530A5 (enExample) | ||
| WO2020214650A1 (en) | Methods and compositions for modulating the immune system | |
| JP2017536826A5 (enExample) | ||
| JP2013507934A5 (enExample) | ||
| JP2015524413A5 (enExample) | ||
| Kher et al. | Antisense oligonucleotides and RNA interference | |
| JP2019505210A5 (enExample) | ||
| CN101972476B (zh) | 利用MicroRNA-155的核酸疫苗佐剂及其构建方法 |